Jinarc 30 mg tablets, Tolvaptan, Jinarc 15 mg tablets, Samsca 7.5 mg tablets
156-201-00307
Phase 3 small_molecule active
Quick answer
Jinarc 30 mg tablets, Tolvaptan, Jinarc 15 mg tablets, Samsca 7.5 mg tablets for Autosomal Recessive Polycystic Kidney Disease is a Phase 3 program (small_molecule) at Otsuka Novel Products GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Otsuka Novel Products GmbH
- Indication
- Autosomal Recessive Polycystic Kidney Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active